Divi's Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For DIVISLAB, that strike is ₹9,300. Spot at ₹9,558.5 is 2.78% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for DIVISLAB is ₹9,300. This is the price at which option writers would incur the smallest aggregate loss, so the market often gravitates toward it as expiry approaches.
Spot vs Max Pain Gap
The spot price sits at ₹9,558.5, about 2.78 % above the max‑pain level. The positive gap suggests that the underlying is still pulling upward, but the distance is narrow enough for the strike to act as a magnetic anchor.
Shift Signal
The max‑pain figure moved down by ₹100 from the previous day, indicating a slight bearish tilt in writer positioning. Writers appear to be hedging more aggressively at lower strikes, which could add downward pressure if the market revisits that zone.
Expiry Context
As the November 23 expiry looms (26 days away), the convergence of open interest around the max‑pain strike typically intensifies. Historically, the final week sees heightened gamma‑scalping and pinning activity, but the max‑pain level remains a probabilistic tendency rather than a deterministic endpoint.
Data Note
The spot is roughly ₹258.5 above the max‑pain strike, with just under a month left until expiry.
Data as of 2026-10-28